Quantitative measurement of pain sensation in patients with Parkinson disease
Abstract
Background: Pain is common in patients with Parkinson disease (PD) and can precede the diagnosis of the disease. Experimental studies and clinical evidence indicate involvement of basal ganglia and dopaminergic pathways in central pain processing.
Objective: To quantitatively assess and compare pain perception in patients with unilateral PD with and without pain and in patients with response fluctuations.
Methods: Thirty-six patients with PD (mean age, 61.8 ± 11.2 years) with predominantly unilateral disease, 15 patients with response fluctuations (mean age, 65.3 ± 10.4 years), and 28 age-matched healthy control subjects participated in the study. Subjective pain was assessed using the visual analog scale with von Frey filaments for tactile thresholds and contact thermode for warm sensation (WS) and heat pain thresholds (HPTs).
Results: Tactile and WS thresholds did not differ between patients in both patient groups and control subjects nor between sides. HPT was lower in patients with PD who experienced pain (n = 21) compared with those who did not (42.6 ± 3.0 °C vs 45.6 ± 2.8 °C; p < 0.01) and those who experienced pain in the more affected side (41.4 ± 2.6 °C vs 43.7 ± 3.3 °C; p < 0.0001). In patients with fluctuations there were no side differences in WS and HPT or between “on” and “off” periods.
Conclusion: Endogenous pain in patients with Parkinson disease is accompanied by increased sensitivity to some painful stimuli, suggesting that basal ganglia abnormality also involves pain encoding.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Ford B. Pain in Parkinson’s disease. Clin Neurosci. 1998; 5: 63–72.
2.
Lev N, Melamed E. Sensory symptoms and pain in Parkinson’s disease. Harefuah. 2000; 138: 324–326.
3.
Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology. 1976; 26: 423–429.
4.
Koller WC. Sensory symptoms in Parkinson’s disease. Neurology. 1984; 34: 957–959.
5.
Quinn NP, Koller WC, Lang AE, Marsden CD. Painful Parkinson’s disease. Lancet. 1986; 1: 1366–1369.
6.
Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain. 1995; 60: 3–38.
7.
Berendse HW, Groenewegen HJ. Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J Comp Neurol. 1990; 299: 187–228.
8.
Malach R, Graybiel AM. Mosaic architecture of the somatic sensory-recipient sector of the cat’s striatum. J Neurosci. 1986; 6: 3436–3458.
9.
Flaherty AW, Graybiel AM. Corticostriatal transformations in the primate somatosensory system. Projections from physiologically mapped body-part representations. J Neurophysiol. 1991; 66: 1249–1263.
10.
Shinonaga Y, Takada M, Mizuno N. Direct projections from the central amygdaloid nucleus to the globus pallidus and substantia nigra in the cat. Neurosci. 1992; 51: 691–703.
11.
Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. Prog Brain Res. 1990; 85: 95–116.
12.
Kemel ML, Desban M, Gauchy C, Glowinski J, Besson MJ. Topographical organization of efferent projections from the cat substantia nigra pars reticulata. Brain Res. 1988; 455: 307–323.
13.
Jobst EE, Melnick ME, Byl NN, Dowling GA, Aminoff MJ. Sensory perception in Parkinson disease. Arch Neurol. 1997; 54: 450–454.
14.
Zia S, Cody FW, O’Boyle DJ. Discrimination of bilateral differences in the loci of tactile stimulation is impaired in subjects with Parkinson’s disease. Clin Anat. 2003; 16: 241–247.
15.
Lewis GN, Byblow WD. Altered sensorimotor integration in Parkinson’s disease. Brain. 2002; 125: 2089–2099.
16.
Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988; 51: 745–752.
17.
Yarnitsky D, Ochoa JL. Studies of heat pain sensation in man: perception thresholds, rate of stimulus rise and reaction time. Pain. 1990; 40: 85–91.
18.
Gao DM, Jeaugey L, Pollak P, Benabid AL. Intensity-dependent nociceptive responses from presumed dopaminergic neurons of the substantia nigra pars compacta in the rat and their modification by lateral habenula inputs. Brain Res. 1990; 529: 315–319.
19.
Harper JA, Labuszewski T, Lidsky TI. Substantia nigra unit responses to trigeminal sensory stimulation. Exp Neurol. 1979; 65: 462–470.
20.
Pay S, Barasi S. A study of the connections of nociceptive substantia nigra neurones. Pain. 1982; 12: 75–89.
21.
Richards CD, Taylor DCM. Electrophysiological evidence for a somatotopic sensory projection to the striatum of the rat. Neursci Lett. 1982; 30: 235–240.
22.
Barnes CD, Fung SJ, Adams WL. Inhibitory effects of substantia nigra on impulse transmission from nociceptors. Pain. 1979; 6: 207–215.
23.
Burkey A, Carstens E, Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci. 1999; 19: 4169–4179.
24.
Schultz W, Romo R. Responses of nigrostriatal dopamine neurones to high intensity somatosensory stimulation in the anesthetized monkey. J Neurophysiol. 1987; 57: 201–217.
25.
Gao X, Zhang Y, Wu G. Effects of dopaminergic agents on carrageenan hyperalgesia in rats. Eur J Pharmacol. 2000; 406: 53–58.
26.
Magnusson JE, Fisher K. The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum. Brain Res. 2000; 855: 260–266.
27.
Shu SY, Penny GR, Peterson GM. The “marginal division:” a new subdivision in the neostriatum of the rat. J Chem Neuroanat. 1988; 1: 147–163.
28.
Shu SY, McGinty JF, Peterson GM. High density of zinc-containing dynorphin B and substance P immunoreactive terminals in the marginal division of the rat striatum. Brain Res Bull. 1990; 24: 201–205.
29.
Simantov R, Kuhar MJ, Pasternak GW, Snyder SH. The regional distribution of a morphine-like factor in monkey brain. Brain Res. 1976; 106: 189–197.
30.
Dennis SG, Melzack R. Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests. Exp Neurol. 1983; 81: 167–176.
31.
Saad’e NE, Atweh SF, Bahuth NB, Jabbur SJ. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res. 1997; 751: 1–12.
32.
Carey RJ. Acute ipsilateral hyperalgesia and chronic contralateral hypoalgesia after unilateral 6-hydroxydopamine lesions of the substantia nigra. Exp Neurol. 1986; 91: 277–284.
33.
Manning BH, Morgan MJ, Franklin KB. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience. 1994; 63: 289–294.
34.
Rosland JH, Hunskaar S, Broch OJ, Hole K. Acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in tests of nociception in mice. Pharmacol Toxicol. 1992; 70: 31–37.
35.
Tracey I, Becerra L, Chang I, et al. Noxious hot and cold stimulation produce common patterns of brain activation in humans: a functional magnetic resonance imaging study. Neurosci Lett. 2000; 288: 159–162.
36.
Hagelberg N, Martikainen IK, Mansikka H, et al. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain. 2002; 99: 273–279.
37.
Jaaskelainen SK, Forssell H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain. 1997; 73: 455–460.
38.
Bouckoms AJ, Sweet WH, Poletti C, et al. Monoamines in the brain cerebrospinal fluid of facial pain patients. Anesth Prog. 1993; 39: 201–208.
39.
Del Zompo M. Dopaminergic hypersensitivity in migraine: clinical and genetic evidence. Funct Neurol. 2000; 15 (suppl 3): 163–170.
40.
Jaaskelainen SK, Rinne JO, Forssell H, et al. Role of the dopaminergic system in chronic pain—a fluorodopa-PET study. Pain. 2001; 90: 257–260.
41.
Hagelberg N, Forssell H, Rinne JO, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain. 2003; 101: 149–154.
42.
Loher TJ, Burgunder JM, Weber S, Sommerhalder R, Krauss JK. Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2002; 73: 395–399.
43.
Schott GD. Pain in Parkinson’s disease. Pain. 1985; 22: 407–411.
44.
Urakami K, Takahashi K, Matsushima E, Sano K, Nishikawa S, Takao T. The threshold of pain and neurotransmitter’s change on pain in Parkinson’s disease. Jpn J Psychiatry Neurol. 1990; 44: 589–593.
45.
Battista AF, Wolff BB. Levodopa and induced-pain response. A study on patients with parkinsonian and pain syndromes. Arch Intern Med. 1973; 132: 70–74.
46.
Guieu R, Pouget J, Serratrice G. Nociceptive threshold and Parkinson disease. Rev Neurol (Paris). 1992; 10: 641–644.
47.
Zaslansky R, Yarnitsky D. Clinical applications of quantitative sensory testing (QST). J Neurol Sci. 1998; 153: 215–238.
48.
Coghill RC, Gilron I, Iadarola MJ. Hemispheric lateralization of somatosensory processing. J. Neurophysiol. 2001; 85: 2602–2612.
49.
Lugo M, Isturiz G, Lara C, Garcia N, Eblen-Zaijur A. Sensory lateralization in pain subjective perception for noxious heat stimulus. Somatosens Mot Res. 2002; 19: 207–212.
50.
Sandyk R. Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson’s disease. Postgrad Med J. 1986; 62: 749–751.
51.
Lees AJ. A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson’s disease. Eur Neurol. 1987; 27: 126–134.
52.
Nappi G, Petraglia F, Martignoni E, Facchinetti F, Bono G, Genazzani AR. β-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology. 1985; 35: 1371–1374.
53.
Agid Y, Cervera P, Hirsch E, et al. Biochemistry of Parkinson’s disease 28 years later: a critical review. Mov Disord. 1989; 4: S126–S144.
Information & Authors
Information
Published In
Copyright
© 2004.
Publication History
Received: October 13, 2003
Accepted: March 30, 2004
Published online: June 21, 2004
Published in print: June 22, 2004
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Pain in Parkinson's disease: a neuroanatomy-based approach, Brain Communications, 6, 4, (2024).https://doi.org/10.1093/braincomms/fcae210
- Effect of deep brain stimulation on sexual dysfunction among patients who had Parkinson’s disease: a systematic review and meta-analysis, Neurological Research, (1-10), (2024).https://doi.org/10.1080/01616412.2024.2407645
- Pathological pain: Non-motor manifestations in Parkinson disease and its treatment, Neuroscience & Biobehavioral Reviews, 161, (105646), (2024).https://doi.org/10.1016/j.neubiorev.2024.105646
- Effect of spinal cord stimulation for thermal noxious stimulus pain threshold in Parkinson's disease, Interdisciplinary Neurosurgery, 36, (101898), (2024).https://doi.org/10.1016/j.inat.2023.101898
- TDCS for parkinson‘s disease disease-related pain: A randomized trial, Clinical Neurophysiology, 161, (133-146), (2024).https://doi.org/10.1016/j.clinph.2024.01.011
- Altered parabrachial nucleus nociceptive processing may underlie central pain in Parkinson’s disease, npj Parkinson's Disease, 9, 1, (2023).https://doi.org/10.1038/s41531-023-00516-x
- Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson’s disease, npj Parkinson's Disease, 9, 1, (2023).https://doi.org/10.1038/s41531-023-00510-3
- Study of the relationship between onset lateralization and hemispheric white matter asymmetry in Parkinson's disease, Journal of Neurology, 270, 10, (5004-5016), (2023).https://doi.org/10.1007/s00415-023-11849-1
- The Role of AlphαSynuclein in Mouse Models of Acute, Inflammatory and Neuropathic Pain, Cells, 11, 12, (1967), (2022).https://doi.org/10.3390/cells11121967
- The mechanism of exercise for pain management in Parkinson’s disease, Frontiers in Molecular Neuroscience, 15, (2022).https://doi.org/10.3389/fnmol.2022.1039302
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.